Advertisement
Screener

CVRx, Inc. (CVRX) Payments of Financing Costs

3.1 / 5 stars · 33/53 Roast Me

CVRx, Inc. Payments of Financing Costs

CVRx, Inc. (CVRX) reported Payments of Financing Costs of $1.11 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-06.

Financial Statements › Cash Flow › Financing Activities

us-gaap:PaymentsOfFinancingCosts · last filed 2026-08-06

  • CVRx, Inc. payments of financing costs for the quarter ending 2026-06-30 was $3.00K.
  • CVRx, Inc. payments of financing costs for the quarter ending 2026-03-31 was $1.11M.
  • CVRx, Inc. payments of financing costs for the quarter ending 2025-12-31 was $0.00, a 100.00% decline year-over-year.
  • CVRx, Inc. payments of financing costs for the quarter ending 2025-09-30 was $0.00, a 100.00% decline year-over-year.
  • CVRx, Inc. payments of financing costs for fiscal 2025 was $0.00, a 100.00% decline from fiscal 2024.
  • CVRx, Inc. payments of financing costs for fiscal 2024 was $152.00K, a 15.08% decline from fiscal 2023.
  • CVRx, Inc. payments of financing costs for fiscal 2023 was $179.00K, a 76.99% decline from fiscal 2022.
  • CVRx, Inc. payments of financing costs for fiscal 2022 was $778.00K.
Period endPayments of Financing Costs 3 monthPayments of Financing Costs 6 monthPayments of Financing Costs 9 monthPayments of Financing Costs 12 month
2026-06-30$3.00K
derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-06
$1.11M
10-Q · filed 2026-08-06
$1.11M
derived: sum of 3 quarters · filed 2026-08-06
$1.11M
derived: sum of 4 quarters · filed 2026-08-06
2026-03-31$1.11M
10-Q · filed 2026-05-12
$1.11M
derived: sum of 2 quarters · filed 2026-05-12
$1.11M
derived: sum of 3 quarters · filed 2026-05-12
$1.11M
derived: sum of 4 quarters · filed 2026-08-06
2025-12-31$0.00
derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-13
$0.00
derived: sum of 2 quarters · filed 2026-02-13
$0.00
derived: sum of 3 quarters · filed 2026-08-06
$0.00
10-K · filed 2026-02-13
2025-09-30$0.00
derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-06
$0.00
derived: sum of 2 quarters · filed 2026-08-06
$0.00
10-Q · filed 2025-11-06
$2.00K
derived: sum of 4 quarters · filed 2026-08-06
2025-06-30$0.00
derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-06
$0.00
10-Q · filed 2026-08-06
$2.00K
derived: sum of 3 quarters · filed 2026-08-06
$152.00K
derived: sum of 4 quarters · filed 2026-08-06
2025-03-31$0.00
10-Q · filed 2026-05-12
$2.00K
derived: sum of 2 quarters · filed 2026-05-12
$152.00K
derived: sum of 3 quarters · filed 2026-05-12
$152.00K
derived: sum of 4 quarters · filed 2026-05-12
2024-12-31$2.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-13
$152.00K
derived: sum of 2 quarters · filed 2026-02-13
$152.00K
derived: sum of 3 quarters · filed 2026-02-13
$152.00K
10-K · filed 2026-02-13
2024-09-30$150.00K
derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-06
$150.00K
derived: sum of 2 quarters · filed 2025-11-06
$150.00K
10-Q · filed 2025-11-06
$262.00K
derived: sum of 4 quarters · filed 2025-11-06
2024-06-30$0.00
derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-02
$0.00
10-Q · filed 2024-08-02
$112.00K
derived: sum of 3 quarters · filed 2025-02-18
$112.00K
derived: sum of 4 quarters · filed 2025-02-18
2024-03-31$0.00
10-Q · filed 2024-05-10
$112.00K
derived: sum of 2 quarters · filed 2025-02-18
$112.00K
derived: sum of 3 quarters · filed 2025-02-18
$119.00K
derived: sum of 4 quarters · filed 2025-02-18
2023-12-31$112.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-18
$112.00K
derived: sum of 2 quarters · filed 2025-02-18
$119.00K
derived: sum of 3 quarters · filed 2025-02-18
$179.00K
10-K · filed 2025-02-18
2023-09-30$0.00
derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-01
$7.00K
derived: sum of 2 quarters · filed 2024-11-01
$67.00K
10-Q · filed 2024-11-01
$845.00K
derived: sum of 4 quarters · filed 2024-11-01
2023-06-30$7.00K
derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-02
$67.00K
10-Q · filed 2024-08-02
$845.00K
derived: sum of 3 quarters · filed 2024-08-02
$845.00K
derived: sum of 4 quarters · filed 2024-08-02
2023-03-31$60.00K
10-Q · filed 2024-05-10
$838.00K
derived: sum of 2 quarters · filed 2024-05-10
$838.00K
derived: sum of 3 quarters · filed 2024-05-10
$838.00K
derived: sum of 4 quarters · filed 2024-05-10
2022-12-31$778.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-09
$778.00K
derived: sum of 2 quarters · filed 2024-02-09
$778.00K
derived: sum of 3 quarters · filed 2024-02-09
$778.00K
10-K · filed 2024-02-09
2022-09-30$0.00
derived: 10-Q 9 month − 10-Q 6 month · filed 2023-10-31
$0.00
derived: sum of 2 quarters · filed 2023-10-31
$0.00
10-Q · filed 2023-10-31
2022-06-30$0.00
derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-03
$0.00
10-Q · filed 2023-08-03
2022-03-31$0.00
10-Q · filed 2023-05-11
2021-12-31$0.00
10-K · filed 2023-02-10

Similar stocks

Stock NameCountryMarket CapPE Ratio
DarioHealth Corp. (DRIO)$0.066B-1.39
FRACTYL HEALTH, INC. (GUTS)United States$0.075B-1.18
RenovoRx, Inc. (RNXT)United States$0.076B-3.62
TELA Bio, Inc. (TELA)United States$0.057B-0.82
Xtant Medical Holdings, Inc. (XTNT)United States$0.053B
Pulmonx Corp (LUNG)United States$0.082B-1.16
Spectral AI, Inc. (MDAI)United States$0.052B
Sensus Healthcare, Inc. (SRTS)United States$0.048B-3.24
SkinHealth Systems Inc. (SKIN)United States$0.086B-3.17
LENSAR, Inc. (LNSR)United States$0.087B2.02